O-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation.
<h4>Background</h4>We analyzed prospectively whether MGMT (O(6)-methylguanine-DNA methyltransferase) mRNA expression gains prognostic/predictive impact independent of MGMT promoter methylation in malignant glioma patients undergoing radiotherapy with concomitant and adjuvant temozolomide...
Guardado en:
Autores principales: | Simone Kreth, Niklas Thon, Sabina Eigenbrod, Juergen Lutz, Carola Ledderose, Rupert Egensperger, Joerg C Tonn, Hans A Kretzschmar, Ludwig C Hinske, Friedrich W Kreth |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fa23620181d841498032e6d200ad0302 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
por: Barbara Oldrini, et al.
Publicado: (2020) -
MIND MGMT: Paranoid Nightmares of a Fugitive Reality.
por: Pepe Rojo
Publicado: (2017) -
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
por: Thomas RP, et al.
Publicado: (2012) -
Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status
por: Ke Wang, et al.
Publicado: (2021) -
A Prospective Clinical Study on MGMT Protein Expression and the Effect of Gene Promoter Methylation on Sensitivity to Chemotherapeutics in Spinal Glioma
por: Sun P, et al.
Publicado: (2021)